Canaccord Genuity Raises Numbers on Dendreon (DNDN); Provenge Outlook Improved on Low Likelihood of New XGEVA Approval
Go back to Canaccord Genuity Raises Numbers on Dendreon (DNDN); Provenge Outlook Improved on Low Likelihood of New XGEVA Approval| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.21 -2.63 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $417.84 | 52 Week High | $176.85 | |||
| Open | $413.76 | 52 Week Low | $133.64 | |||
| Day High | $416.03 | P/E | 62.53 | |||
| Day Low | $410.50 | EPS | $6.64 | |||
| Volume | 2,036,286 | |||||
| Dendreon Corp (NASDAQ: DNDN) | Delayed: 0.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $3.46 | |||
| Open | $11.75 | 52 Week Low | $0.11 | |||
| Day High | $0.13 | P/E | N/A | |||
| Day Low | $0.13 | EPS | $-1.63 | |||
| Volume | 279 | |||||
